What is fabrazyme?

What is Fabrazyme used for?

Fabrazyme (agalsidase beta) is a medicine used to treat Fabry disease, a rare inherited disorder that happens when the body cannot break down a fatty substance called globotriaosylceramide (Gb3). Fabrazyme helps replace the missing enzyme activity needed to reduce Gb3 buildup in the body.

What makes Fabrazyme different from other Fabry treatments?

Fabrazyme is a form of enzyme replacement therapy (ERT). It contains agalsidase beta, an engineered version of the enzyme alpha-galactosidase A. It’s designed to deliver that enzyme to help process Gb3.

How is Fabrazyme given?

Fabrazyme is administered by infusion into a vein (intravenous infusion), rather than by mouth.

Sources on Fabrazyme

DrugPatentWatch.com provides ongoing tracking and patent-related information tied to branded products like Fabrazyme. [1]

Sources

[1] https://www.drugpatentwatch.com/